Project Grant R01EY035624

Award Date 9/1/24
Completion Date 5/31/28
Dollars Obligated $543K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $753,189 to Boston University Medical Campus to conduct research on the role of basal epithelial cells in maintaining a healthy corneal epithelium and enabling corneal wound healing. The project aims to reveal the heterogeneity of basal epithelial cells across the central cornea, limbus, and conjunctiva, and determine the functional roles of genes expressed in these cells...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will support research to characterize the composition and function of Optix-cofactor transcription complexes in the development of the fly eye and brain. The $448,250 award, granted on May 1, 2025, will enable the Research Foundation for the State University of New York, through its Upstate Medical Center, to conduct investigations into how the transcription factor Optix...
This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to investigate the role of light modulation in corneal wound healing via an opsin-dependent mechanism. The $441,250 award, spanning from September 1, 2024 to May 31, 2029, will be executed by the University of Washington's Office of Sponsored Programs. The key research objectives include: 1) Testing the light regimen necessary for accelerating photic healing in...
This $148,568 federal Project Grant awarded by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research conducted by Emory University to investigate the role of scleral fibroblasts in refractive development and myopia. The study aims to identify the characteristics of scleral fibroblasts in emmetropic eyes and compare changes that occur in mice exposed to myopic stimuli, including lens-induced myopia and retinoic acid treatment. The research also seeks...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides USD 366,399 to the Trustees of Indiana University to fund research on the role of the PAX6 transcription factors in specifying and patterning the Drosophila (fruit fly) compound eye. The overarching goal is to understand how the earliest steps in eye formation are controlled, with a focus on the individual and combined contributions of the PAX6 genes Eyeless (Ey)...
This federal Project Grant award of $488,639 from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), aims to investigate the enhanced virulence mechanisms of an extensively drug-resistant (XDR) strain of Pseudomonas aeruginosa that has caused a concerning outbreak of bacterial keratitis. The study will systematically evaluate the unique virulence factors of this outbreak strain and test FDA-approved antimicrobials and combinations to mitigate the threat. The...
The National Eye Institute (NEI) awarded a $176,550 Project Grant under the Vision Research program (CFDA 93.867) to the University of Louisville to optimize c-Met signaling in order to enhance corneal epithelial homeostasis. The project aims to determine if inhibiting the downregulation of the c-Met receptor can prolong its signaling and accelerate corneal wound healing, as well as decrease fibrosis and promote nerve restoration in the cornea. The research will be conducted through in vitro...
The National Eye Institute (NEI) awarded a $237,996 Project Grant (CFDA 93.867 - Vision Research) to The Regents of the University of Colorado to investigate groundbreaking approaches for in-vivo high-resolution imaging of the cornea. The project aims to develop a new imaging technique using speckle illumination holographic imaging with polarization and phase-sensitive detection. This approach seeks to provide wide field-of-view, confocal-like sectioning capability, and the ability to...
This Project Grant award of $285,504 from the National Eye Institute (CFDA 93.867 Vision Research) will fund research to develop a novel combined optical coherence elastography (OCE) and Brillouin microscopy system. The objective is to quantitatively evaluate the depth-dependent biomechanical properties of the human lens in vivo, which is critical for understanding and treating presbyopia. The research will validate the system's performance in ex-vivo porcine lenses and then test it for...
This federal Project Grant award of $154,332 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research at New York University (NYU) to investigate the molecular mechanisms underlying the assembly of the color vision circuit in the fruit fly Drosophila. The key objectives of the award are to: 1) Characterize the neural circuitry underlying color vision in the fly brain through electron microscopy-based connectomics analysis; 2) Identify cell surface...

This $543,037 federal Project Grant award, issued by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), supports research to understand the development and function of corneal lens-secreting cells in the Drosophila corneal lens model. The research aims to: 1) identify transcription factors and chromatin changes regulating the differentiation of cone and pigment cells that secrete the corneal lens; 2) examine how the timing of cone and pigment cell differentiation, controlled by ecdysone signaling, impacts corneal lens morphology; and 3) characterize the molecular and structural components of the Drosophila corneal lens to establish its utility as a model for understanding human corneal disorders. The award was made to New York University School of Medicine, a prominent academic medical center, and runs from September 1, 2024 through May 31, 2028. The research findings may provide insights into the genetic basis of visual disorders like myopia, hyperopia, astigmatism, keratoconus, and corneal dystrophy, potentially leading to new treatment approaches.

Generated 6/17/25, 2:29 AM